Salvage metastasis-directed therapy versus elective nodal radiotherapy for oligorecurrent nodal prostate cancer metastases (PEACE V-STORM): a phase 2, open-label, randomised controlled trial.

Auteurs

Ost P, Siva S, Brabrand S, Dirix P, Liefhooghe N, Otte FX, Gomez-Iturriaga A, Everaerts W, Shelan M, Conde-Moreno A, López Campos F, Papachristofilou A, Guckenberger M, Scorsetti M, Zapatero A, Villafranca Iturre AE, Eito C, Couñago F, Muto P, Duthoy W, Mach N, Fonteyne V, Moon D, Thon K, Mercier C, Achard V, Stellamans K, Goetghebeur E, Reynders D, Zilli T

  • Date de publication

    May 2025
  • Type

    Article
  • Review

    Lancet Oncol
  • Researcher's name

    OTTE FRANCOIS-XAVIER
  • Hôpital

    Institut Jules Bordet
  • Service

    Radiothérapie
  • PMID

    40339593
  • DOI

    10.1016/S1470-2045(25)00197-4